In 2005, UIC unveiled its College of Medicine Research Building. Located on Wolcott Avenue, the building increased UIC’s research space by 15% and is the largest new building constructed on the Chicago campus in a quarter century. The building supports an estimated $35 million in new research annually, in addition to the nearly $110 million College of Medicine researchers annually attract from the National Institutes of Health and other public and private granting agencies. The $145 million facility includes 116 modern research laboratories for 80 faculty principal investigators and 700 researchers and students.
The University of Illinois Medical Center’s Cancer Team brings together researchers, physicians and scientists from various disciplines and throughout it’s campuses to study and improve the care, prevention and treatment of cancer. This is achieved by promoting collaborative research activities including basic, clinical, prevention and control studies, providing education and training for healthcare professionals, as well as outreach activities with the community and region. Our doctors get more information to help solve problems. You get A Higher Level of Care.
Our patients and their families benefit from leading-edge cancer care resulting from our close relationship with the University of Illinois at Chicago. Not only do our patients benefit from the latest in research and clinical trial research but they also receive a patient-focused treatment plan that addresses both the physical and emotional needs of our patients in a comfortable, private and healthy environment. In our Outpatient Care Center, we offer a large number of screening clinics that seek to identify, diagnose, and treat cancers at their earliest stages to provide our patients with the best possible treatment outcomes. Below, you will find a number of currently available Clinical Trials as well as Screening and Prevention Programs offered at the MedicalCenter.
Clinical Trials
The University of Illinois at Chicago has over 175 IRB-approved cancer clinical trials. If you would like to find out more information about a particular clinical trial, please contact the Cancer Center at (312) 355-3046.
Screening and Prevention Programs
Colon Cancer Screening Clinic The purpose of this clinic is to identify and educate patients who should have a colonoscopy for the early detection of colon cancer. Patients will complete a questionnaire and have a physical exam (including a fecal occult blood test) to determine if they are appropriate candidates for this procedure. Contact: Karen Bednar, RN, APN (312) 355-4071 and Elisa Stamm Kogan, (312) 355-0752 When: Thursday afternoons (4 hour clinic) Where: Oncology Care Center (OCC South) - Nutrition & Wellness Center. 1801 W. Taylor, first floor.
Melanoma Screening Program The purpose of this screening program is to identify and educate people who should have a thorough skin cancer screening for the early detection of melanoma cancer. At the screenings, participants identify potential moles that they are concerned about. A physician or nurse asks for a complete family medical history. The physician then screens their body. A recommendation will be given to either watch the moles or for a participant to go to a specific clinic at which time further diagnostic testing can be done. This screening happens about three times a year. Contact: Pat Kavanaugh, RN, (312) 996-2366 When: Throughout year (health fairs, education programs) Where: Different Locations (hospitals/clinics)
STAR Trial
The Cancer continues to take part in the Study of Tamoxifen and Raloxifene (STAR), the nation wide breast cancer prevention trial sponsored by the National Surgical Adjuvant Breast and Bowel Project (NSABP). This study is targeting post-menopausal women over 35 years of age who have a high risk of developing breast cancer as calculated by the Gail Model. These women will take part in a double blind, randomized trial comparing the effectiveness of Tamoxifen and Raloxifene in the prevention of breast cancer. STAR will begin its fourth year of accrual in June, with the goal of enrolling 22,000 women in five years. For information on eligibility and enrollment contact the study coordinator: Judith Murray, MS, at (312) 355-1472.
SELECT Trial
The Cancer Center is also a participating in The Selenium and Vitamin E Cancer Prevention Trial (SELECT), a double blind randomized study for prostate cancer prevention. Men aged 55 and older (50 and older for African American men) who are in good health with a normal PSA are encouraged to enroll in this trial. The target accrual is 32,000 men and since its opening in July 2001, over 10,200 men have been randomized. The subjects will take the supplements for 7 to 12 years, depending on when they are randomized. SELECT has been designed to be convenient for the participants, requiring only 2 study visits per year. For further information, please contact the study coordinator: Patricia Tiller, RN, at (312) 413-4252.
Close
The University of Illinois Medical Center’s Cancer Team brings together researchers, physicians and scientists from various disciplines and throughout it’s campuses to study and improve the care, prevention and treatment of cancer. This is achieved by promoting collaborative research activities including basic, clinical, prevention and control studies, providing education and training for healthcare professionals, as well as outreach activities with the community and region. Our doctors get more information to help solve problems. You get A Higher Level of Care.